This article is more than 5 years old. Information may no longer be current.

Ortho-tag Inc. and the University of Pittsburgh enter into licensing agreement

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Ortho-tag Inc. has entered into a global licensing agreement with the University of Pittsburgh to use transcutaneous near field communication technology in “smart” medical devices for orthopedic implants and recipient patients, according to a press release.

Transcutaneous near field communication enables the transcutaneous transmission of information between the patented Orthotag affixed to an orthopedic implant and a proprietary Ortho-tag Touch Probe/Reader. The Orthotag allows an orthopedic surgeon to identify vital information about a patient’s implant. The technology also includes the Ortho-tag Card, which gives patients the ability to have information related to their implant or surgery with them at all times.

“This technology will bring patient care to an all new level and is not only designed for surgeons, but driven by surgeons,” Ken Laing, Ortho-tag’s chief executive officer, stated in the release.